Table 5.
Prevalence of PPNG, TRNG, and CRNG according to consultation motifs.
| Reason for visiting | PPNG+ | TRNG+ | CRNG+ | ||||
|---|---|---|---|---|---|---|---|
| N (%) | P-value | N (%) | P-value | N (%) | P-value | ||
| Prenatal consultation | No | 34(94.4) | 0.025 | 62(89.9) | 0.019 | 94(81.0) | 0.616 |
| Yes | 2(5.6) | 7(10.1) | 22(19.0) | ||||
|
| |||||||
| Genital symptoms | No | 28(77.8) | 0.167 | 54(78.3) | 0.017 | 78(67.2) | 0.550 |
| Yes | 8(22.2) | 15(21.7) | 38(32.8) | ||||
|
| |||||||
| Infertility | No | 35(97.2) | 0.462 | 65(94.2) | 0.484 | 111(95.7) | 0.484 |
| Yes | 1(2.8) | 4(5.8) | 5(4.3) | ||||
PPNG, penicillinase-producing N. gonorrhoeae (plasmid-mediated); TRNG, tetracycline resistant N. gonorrhoeae (plasmid-mediated); CRNG: ciprofloxacin-resistant N. gonorrhoeae.